αααααβααΎαDXCM β’ NASDAQ
add
DexCom Inc
66.37$
αααααααααα(0.015%)+0.0100
66.38$
ααΆααα·αα 31 ααααΌ, 8:00:00 PM ααααβααα -5 · USD · NASDAQ · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·αααΆαααΈααααΆααααΆααααααΆααα
α’αΆαααα·α
αα·αααΈαα»α
67.06$
α
αααααααααααα
66.00$ - 67.15$
α
ααααααα½αααααΆαα
α»αααααα
54.11$ - 93.24$
ααΎαβαα»αβααΈααααΆα
25.89Β αααΈααΆα USD
ααα ααα½αααΌαααααα
4.92Β ααΆα
α’αα»ααΆα P/E
37.52
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
NASDAQ
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 1.21Β αααΈααΆα | 21.64% |
α
αααΆαααααα·ααααα·ααΆα | 488.90Β ααΆα | 10.66% |
α
αααΌααα»ααα | 283.80Β ααΆα | 110.85% |
ααααΆααα
αααααα»ααα | 23.47 | 73.34% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | 0.61 | 35.56% |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 306.10Β ααΆα | 47.66% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 19.44% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 3.32Β αααΈααΆα | 33.29% |
ααααααααα»α | 7.50Β αααΈααΆα | 18.04% |
ααΆαααα½ααα»αααααΌαααα»α | 4.77Β αααΈααΆα | 9.12% |
ααΌαβααααα»α | 2.73Β αααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 390.02Β ααΆα | β |
ααααααααααΉαααααα
| 9.59 | β |
ααα
ααααααΎαααααα | 8.18% | β |
ααα
ααααααΎααΎααα»α | 11.60% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (USD) | αααααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 283.80Β ααΆα | 110.85% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 659.90Β ααΆα | 230.78% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 192.80Β ααΆα | -8.32% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -175.00Β ααΆα | 76.24% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 676.60Β ααΆα | 312.70% |
ααα αΌαααΆα
αααααΆααααααα | 406.62Β ααΆα | 740.79% |
α’αααΈ
Dexcom, Inc. is an American healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland. Wikipedia
ααΆααααααΎαα‘αΎα
1999
ααΆαα·ααΆαααβαααααΆα
αααααβαααααΆα
αα»ααααα·α
10,250
